The value of serum anti-Müllerian hormone and inhibin-B levels for evaluating ovarian function in children with Turner syndrome

Dong-Guang ZHANG, Ya-Ping YU, Yu YANG, Li YANG, Li-Ling XIE, Li ZHOU, Xin-Ju HU

Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (8) : 978-983.

PDF(624 KB)
HTML
PDF(624 KB)
HTML
Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (8) : 978-983. DOI: 10.7499/j.issn.1008-8830.2512079
CLINICAL RESEARCH

The value of serum anti-Müllerian hormone and inhibin-B levels for evaluating ovarian function in children with Turner syndrome

Author information +
History +

Abstract

Objective To determine serum anti-Müllerian hormone (AMH) and inhibin-B (INHB) levels in children with Turner syndrome (TS) across different karyotypes, and to assess their value in ovarian reserve assessment. Methods Clinical data of 79 girls with TS (divided into monosomy, mosaic, and other karyotype groups) and 50 healthy girls (control group) were retrospectively analyzed. Differences among groups were compared. Correlations of AMH and INHB with sex hormones, ovarian volume, and spontaneous puberty were analyzed. Receiver operating characteristic (ROC) curves were used to evaluate the predictive efficacy of AMH and INHB for ovarian reserve function. Results Serum AMH and INHB levels, as well as ovarian and uterine volumes, were significantly lower in the TS group than in the control group (P<0.001), while follicle-stimulating hormone (FSH) levels were significantly higher (P<0.001). The mosaic group had significantly higher AMH and INHB levels than the monosomy and other karyotype groups (P<0.05). Girls with spontaneous puberty showed higher AMH and INHB levels than those without (P<0.05). AMH levels were negatively correlated with luteinizing hormone (LH) and FSH (P<0.05), and positively correlated with ovarian volume (P<0.05). The area under the ROC curve of AMH for predicting ovarian reserve function was 0.748 (95%CI: 0.615-0.853, P<0.001), with an optimal cutoff value of 0.225 ng/mL and specificity of 95.5%. The area under the ROC curve of INHB was 0.659 (95%CI: 0.521-0.787, P=0.015). Conclusions Serum AMH and INHB levels in children with TS correlate with karyotype and spontaneous puberty. AMH is a superior indicator for assessing ovarian reserve function in these children.

Key words

Turner syndrome / Karyotype / Ovarian reserve function / Anti-Müllerian hormone / Inhibin-B / Child

Cite this article

Download Citations
Dong-Guang ZHANG , Ya-Ping YU , Yu YANG , et al . The value of serum anti-Müllerian hormone and inhibin-B levels for evaluating ovarian function in children with Turner syndrome[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(8): 978-983 https://doi.org/10.7499/j.issn.1008-8830.2512079

References

[1]
Porcu E, Cipriani L, Damiano G. Reproductive health in Turner's syndrome: from puberty to pregnancy[J]. Front Endocrinol (Lausanne), 2023, 14: 1269009. PMCID: PMC10728473. DOI: 10.3389/fendo.2023.1269009 .
[2]
Sibi K, Blesson SS, Ganesha M, et al. Early diagnosis and multidisciplinary management of Turner syndrome: a paediatric case study[J]. Adv Phar Clin Tria, 2024, 9(4): 000253. DOI: 10.23880/apct-16000253 .
[3]
Guo H, Chen H, Chen S, et al. Turner syndrome with pulmonary arteriovenous malformation: a case report[J]. Front Cardiovasc Med, 2025, 12: 1603250. PMCID: PMC12422892. DOI: 10.3389/fcvm.2025.1603250 .
[4]
Mirhosseini NA, Mirhosseini S, Saeida-Ardekani M. Turner syndrome and beta thalassemia major: a rare association[J]. World J Peri Neonatol, 2023, 5(2): 99-101. DOI: 10.18502/wjpn.v5i2.11997 .
[5]
Klamut N, Bothwell S, Carl AE, et al. Prevalence, diagnostic features, and medical outcomes of females with Turner syndrome with a trisomy X cell line (45,X/47,XXX): results from the insighTS registry[J]. Am J Med Genet A, 2024, 194(12): e63819. PMCID: PMC11540750. DOI: 10.1002/ajmg.a.63819 .
[6]
Xharra S, Behluli E, Moder A, et al. Association of X chromosome aberrations with male infertility[J]. Acta Med Bulg, 2021, 48(4): 69-72. DOI: 10.2478/amb-2021-0051 .
[7]
Shtaut MI, Solovova OA, Sorokina TM, et al. Spermatogenesis and meiosis defects in patients with mosaicism and/or the Y chromosome structural abnormalities[J]. Androl Genit Surg, 2025, 25(4): 64-75. DOI: 10.62968/2070-9781-2024-25-4-64-76 .
[8]
Bin-Abbas B, Jabari M. Anti-Müllerian hormone as a biomarker of ovarian function and spontaneous puberty in Turner syndrome: a systematic review[J]. Front Endocrinol (Lausanne), 2025, 16: 1640583. PMCID: PMC12477649. DOI: 10.3389/fendo.2025.1640583 .
[9]
Shigeyama M, Yoshihara M, Kitami K, et al. Long-term post-recurrence survival outcomes in young women receiving fertility-sparing surgery for epithelial ovarian cancer[J]. Eur J Obstet Gynecol Reprod Biol, 2021, 267: 221-225. DOI: 10.1016/j.ejogrb.2021.11.015 .
[10]
中国人体健康科技促进会生育力保护与保存专业委员会. 特纳综合征中国专家共识(2022年版)[J]. 中国实用妇科与产科杂志, 2022, 38(4): 424-433. DOI: 10.19538/j.fk2022040111 .
[11]
Purushothaman R, Lazareva O, Oktay K, et al. Markers of ovarian reserve in young girls with Turner's syndrome[J]. Fertil Steril, 2010, 94(4): 1557-1559. DOI: 10.1016/j.fertnstert.2009.12.026 .
[12]
Pasquino AM, Passeri F, Pucarelli I, et al. Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's Syndrome[J]. J Clin Endocrinol Metab, 1997, 82(6): 1810-1813. DOI: 10.1210/jcem.82.6.3970 .
[13]
Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls[J]. Arch Dis Child, 1969, 44(235): 291-303. PMCID: PMC2020314. DOI: 10.1136/adc.44.235.291 .
[14]
Bustamante Velez VH, Dowlut-McElroy T, Kanakatti Shankar R. Perception and attitude towards fertility and fertility preservation options in parents of children with Turner syndrome: a qualitative survey study[J]. J Pediatr Adolesc Gynecol, 2025, 38(6): 667-673. DOI: 10.1016/j.jpag.2025.07.008 .
[15]
van der Coelen S, van der Velden J, Nadesapillai S, et al. Navigating fertility dilemmas across the lifespan in girls with Turner syndrome: a scoping review[J]. Hum Reprod Update, 2024, 30(4): 383-409. PMCID: PMC11215162. DOI: 10.1093/humupd/dmae005 .
[16]
Choukair D, Mittnacht J, Bettendorf M. Markers of fertility in adolescents with chronic endocrinopathies at transition from paediatric to adult care[J]. Endocrinol Diabetes Metab, 2024, 7(4): e00493. PMCID: PMC11157144. DOI: 10.1002/edm2.493 .
[17]
Mascoe C, Mumford K, Badger TC, et al. 110. Ovarian tissue histopathology and correlation to serum markers in Turner syndrome[J]. J Pediatr Adolesc Gynecol, 2023, 36(2): 220. DOI: 10.1016/j.jpag.2023.01.253 .
[18]
Iwase A, Hasegawa Y, Tsukui Y, et al. Anti-Müllerian hormone beyond an ovarian reserve marker: the relationship with the physiology and pathology in the life-long follicle development[J]. Front Endocrinol (Lausanne), 2023, 14: 1273966. PMCID: PMC10657644. DOI: 10.3389/fendo.2023.1273966 .
[19]
Hagen CP, Aksglaede L, Sørensen K, et al. Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients[J]. J Clin Endocrinol Metab, 2010, 95(11): 5003-5010. DOI: 10.1210/jc.2010-0930 .
[20]
Visser JA, Hokken-Koelega AC, Zandwijken GR, et al. Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment[J]. Hum Reprod, 2013, 28(7): 1899-1907. DOI: 10.1093/humrep/det089 .
[21]
Wang J, Lan T, Dai X, et al. The cut-off value of serum anti-Müllerian hormone levels for the diagnosis of Turner syndrome with spontaneous puberty[J]. Int J Endocrinol, 2023, 2023: 6976389. PMCID: PMC9949959. DOI: 10.1155/2023/6976389 .
[22]
van der Coelen S, Nadesapillai S, Peek R, et al. Puberty progression in girls with Turner syndrome after ovarian tissue cryopreservation[J]. Fertil Steril, 2025, 123(4): 583-592. DOI: 10.1016/j.fertnstert.2024.10.025 .

Footnotes

所有作者均声明无利益冲突。

PDF(624 KB)
HTML

Accesses

Citation

Detail

Sections
Recommended

/